Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders

SIMPLE SUMMARY: Low-dose aspirin has a preventive effect against multiple malignancies, including hepatocellular carcinoma. Whether aspirin could also ameliorate the prognosis of patients who already developed advanced cancer remains an elusive question. In the case of hepatocellular carcinoma, rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Ielasi, Luca, Tovoli, Francesco, Tonnini, Matteo, Tortora, Raffaella, Magini, Giulia, Sacco, Rodolfo, Pressiani, Tiziana, Trevisani, Franco, Sansone, Vito, Marasco, Giovanni, Piscaglia, Fabio, Granito, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699252/
https://www.ncbi.nlm.nih.gov/pubmed/34944996
http://dx.doi.org/10.3390/cancers13246376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699252/
https://www.ncbi.nlm.nih.gov/pubmed/34944996
http://dx.doi.org/10.3390/cancers13246376

Ejemplares similares